| Time | Session |
|---|---|
| 08:00 am - 9:00 am | Registration & Networking Tea |
| 09:00 am - 09:10 am | Welcome Address from Express Pharma + Lamp lighting |
| 09:10 am - 09:50 am |
Leadership Lens Defining India’s next global edge Mr Suresh Pattathil, MD & GM, AbbVie India (MODERATOR) Dr Villoo Morawala Patell, Founder, Avesthagen and Avestagenome Project International Dr Rhonda Duffy, COO, Biocon Dr Murali Ramachandra, CEO, Aurigene Oncology |
| 09:50 am - 10:05 am |
Hydrocel: Multi-Functional Cellulose Technologies for Modern Formulators Mr Vaibhav Doshi, Director – Operations, Pioma Chemicals |
| 10:05 am - 10:20 am |
Analytical Characterization of Critical Quality Attributes (CQAs) in Biologics Dr Sundaram Palaniswamy, Senior Global Product Manager – Analytical Chemistry, Merck Lifescience |
| 10:20 am - 10:35 am |
Drug release modulation through DRUGCOAT RSPO/RLPO Mr Krutik Prajapati, Manager (Techno Commercial), Vikram Thermo (India) |
| 10:35 am - 10:50 am |
Beyond the Pharmacy of the World: How India Can Become the World’s Most Trusted Innovation Partner Dr Parthasarathy Sampathkumar, Head Group - COE, Biocon |
| 10:50 am – 11:05 am |
Tale of Two CDMOs – Building Boundless Visibility Mr Vasudevan (Vasu) Ramanujam, Global Business Head, Innovation Acceleration Services, UST |
| 11:05 am – 11:20 am |
Rethinking Cleanroom Garment Management Mr Prashanth Bajaj, Business Unit Director, Lindstrom Services India |
| 11:20 am - 11:35 am |
Empowering Excellence Through Innovation in the Pharmaceutical Industry Dr Pravin Mhapankar, Director, Thermolab Scientific Equipments |
| 11:35am - 12:25 pm |
PANEL DISCUSSION The new innovation economy: Building the ecosystem behind the molecule Dr Maneesh Paul. S., M.Sc, Ph.D, FIDSA, CEO, Microvioma (MODERATOR) Ms Kavitha Iyer Rodrigues, Founder & CEO, Zumutor Biologics Dr Anandkrishna Kulkarni, VP & Head-Global Program Office and Operational Excellence, Syngene International Dr M.S. Vijaykanth, M.Pharm, Ph.D., Sr VP and Head R&D Formulations, OneSource Specialty Pharma Dr Mohamed Adil, MD, Bangalore Bioinnovation Centre Dr Rakesh Kumar Bhasin, Head GF R&D, Biocon Pharma Dr Huzaifa S Choonia, AVP and Head, Drug Substance MSAT, OneSource Specialty Pharma Dr Shailendra Gaur, Director, Process Science, Aspergen Inc (Cipla and Kemwell’s JV) |
| 12:25 pm - 12:40 pm |
The strategic shift: Why CDMOs are becoming central to pharma growth Mr Loganathan S, AVP, Onesource Biopharma |
| 12:40 pm - 02:00 pm | Networking Lunch |
| 02:00 pm - 02:20 pm | Lucky Draw |
| 02:20 pm - 02:35 pm | Unconference |
| 02:35 pm - 03:25 pm |
PANEL DISCUSSION The biopharma pivot: Can India move from manufacturing medicines to inventing them? Dr Sanjib Banerjee, COO (Biopharma Services), Veeda Lifesciences (MODERATOR) Dr Jayashree Aiyar, CSO, Syngene International Dr Maloy Ghosh, CSO, Zumutor Biologics Dr Rajkumar Aland, Assistant VP, Bioplus Life Science Mr Aditya Viswanath Garimella, Associate Director, Corporate Quality Control, OneSource Specialty Pharma Dr Amarnath Chatterjee, Head analytical sciences Cipla Biosimilars, Cipla Dr Subhra Prakash Chakrabarty, Director and Head, Antibody Engineering, Aurigene Oncology |
| 03:25 pm - 03:45 pm | Lucky Draw |
| 03:45 pm - 04:35 pm |
PANEL DISCUSSION The Bengaluru Bet: How GCCs are redefining India Pharma Inc Dr Mahesh Bhalgat, CEO and Founder, AAPM Therapeutics (MODERATOR) Dr Gursharan Singh, GM - Medical Sciences, Clinical Development, Biocon Dr Raghavender Gunda, Head-R&D QA, VJ Biosciences Mr Shrenik Kole, VP and Head Sterile Product Development, Micro Lab Dr Goutam Pujari, VP, Clinical Research and R&D, Apotex Research Dr Manoj Kumar Singh, Sr VP, Micro Labs Mr Siddalingaswamy, VP Operations, Zuventus Healthcare Limited (Emcure Group) Mr Kesavalu Purushothaman, GM – Formulation Development, Lyrus Life Sciences Dr Nandakumar Sundaramoorthy, Associate VP, OneSource Specialty Pharma |
| 04:35 pm - 04:45 pm | Vote of thanks |
| 04:45 pm onwards | Networking Hi-Tea |